Bevacizumab in the treatment of non-small-cell lung cancer with brain metastases

doi:10.3760/cma.j.issn.1673-422X.2017.11.015

Abstract

Abstract: The occurrence of brain metastases in lung cancer affects the prognosis of patients. Following surgery, whole brain radiotherapy, stereotactic radiotherapy and chemotherapy, antiangiogenesis therapy has become a new treatment option for lung cancer patients with brain metastases. As an antiangiogenic drug, bevacizumab has a better effect of controlling peritumoral edema. Studies have shown that bevacizumab combined with chemotherapy, radiotherapy to treat nonsmall cell lung cancer with brain metastasis has a good efficacy and safety.

Key words: Carcinoma, non-small cell lung, Neoplasm metastases, Bevacizumab

刘梦实，杨海燕，李红梅. Bevacizumab in the treatment of non-small-cell lung cancer with brain metastases[J]. Journal of International Oncology, 2017, 44(11): 864-865.

References

［1］ Wu W, Tang J, Wu Y, et al. Longterm survival of a patient with advanced nonsmall cell lung cancer on bevacizumab therapy: case report and review of the literature［J］. Zhongguo Fei Ai Za Zhi, 2013, 16(6): 325-329. DOI: 10.3799/j.issn.1009-3419.2013.06.10. ［2］刘贤忠, 张丽婷, 陈芳. 贝伐单抗联合化疗治疗肺癌的研究新进展［J］. 实用肿瘤杂志, 2015, 30(4): 385389. DOI: 10.13267/j.cnki.syzlzz.2015.04.024. ［3］ Lou E, Sperduto PW. Integrating bevacizumab and radiation treatment of brain metastasis: is there sense and sensibility in this approach?［J］. Ann Transl Med, 2016, 4(2): 36. DOI: 10.3978/j.issn.2305-5839.2015.12.42. ［4］ Fischer I, Cunliffe CH, Bollo RJ, et al. Highgrade glioma before and after treatment with radiation and Avastin: initial observations［J］. Neuro Oncol, 2008, 10(5): 700-708. DOI: 10.1215/15228517-2008-042. ［5］ Rinne ML, Lee EQ, Nayak L, et al. Update on bevacizumab and other angiogenesis inhibitors for brain cancer［J］. Expert Opin Emerg Drugs, 2013, 18(2): 137-153. DOI: 10.1517/14728214.2013.794784. ［6］张欢欢, 岳文, 付艳, 等. 贝伐珠单抗治疗肺癌脑转移伴难治性瘤周水肿的疗效观察［J］. 川北医学院学报, 2017, 32(2): 178-181. DOI: 10.3969/j.issn.1005-3697.2017.02.007. ［7］ Zustovich F, Ferro A, Lombardi G, et al. Bevacizumabbased therapy for patients with brain metastases from nonsmallcell lung cancer: preliminary results［J］. Chemotherapy, 2014, 60(5-6): 294-299. DOI: 10.1159/000376605. ［8］ Socinski MA, Langer CJ, Huang JE, et al. Safety of bevacizumab in patients with nonsmallcell lung cancer and brain metastases［J］. J Clin Oncol, 2009, 27(31): 5255-5261. DOI: 1200/JCO.2009.22.0616. ［9］ Zustovich F, Ferro A, Lombardi G, et al. Bevacizumab as frontline treatment of brain metastases from solid tumors: a case series［J］. Anticancer Res, 2013, 33(9): 4061-4065. ［10］杨晓利, 王峰, 何炜, 等. 贝伐单抗联合培美曲塞加顺铂一线治疗Ⅳ期非小细胞肺癌的临床观察［J］. 西安交通大学学报: 医学版, 2013, 34(4): 554-556. ［11］ Lévy C, Allouache D, Lacroix J, et al. REBECA: a phase Ⅰ study of bevacizumab and wholebrain radiation therapy for the treatment of brain metastasis from solid tumours［J］. Ann Oncol, 2015, 26(11): 2359. DOI: 10.1093/annonc/mdv386. ［12］王小磊, 刘德泽, 刘微微, 等. 非小细胞肺癌脑转移的治疗［J］. 国际肿瘤学杂志, 2015, 42(6): 455-457. DOI: 10.3760/cma.j.issn.1673-422X.2015.06.015.

[1]	Lin Rongsheng, Wu Chuhai, Guo Yingmei, Wang Tao, Chen Rongbin, Liu Shaoqin, Gan Bing. Efficacy and safety of teriprizumab combined with bevacizumab in the treatment of metastatic MSI-H colorectal cancer above the second line [J]. Journal of International Oncology, 2022, 49(2): 100-105.
[2]	Li Jia, Ma Xiaojie, Wang Yuxiang. Evaluation of the efficacy and safety of adjuvant mFOLFOX6 combined with bevacizumab regimen in the treatment of colorectal cancer liver metastases after radiofrequency ablation [J]. Journal of International Oncology, 2021, 48(12): 729-734.
[3]	Zheng Jing, Yao Sheng, Shen Wenjie, Sun Zhijia, Zhao Hui, Fu Yan, Gao Ke, Du Nan. Clinical study of intraperitoneal infusion of bevacizumab combined with albumin paclitaxel and carboplatin in carcinomatous peritoneal adhesion from ovarian cancer [J]. Journal of International Oncology, 2021, 48(11): 660-665.
[4]	Quan Ruiquan, Zhang Li, Kuang Li, Li Hongbo, Xiao Meixian. Efficacy of olaparib combined with bevacizumab in the treatment of patients with recurrent platinum-sensitive ovarian cancer and its effect on serum HE4, CA125 and CTC levels [J]. Journal of International Oncology, 2020, 47(10): 606-610.
[5]	Teng Fei, Cui Guimin, Shi Hongyun, Liu Miaoling, Li Yanhong. Clinical observation of radiotherapy combined with temozolomide in non-small cell lung cancer patients with brain metastases [J]. Journal of International Oncology, 2017, 44(4): 271-273.
[6]	Yu Lan, Zhang Xiaotao, Liu Li, Han Xiaona. Application of bevacizumab for malignant brain edema [J]. Journal of International Oncology, 2017, 44(1): 41-44.
[7]	HOU Su-Juan, LIU Yuan-Shui, ZHAO Wen-Hua. Efficacy of cryoablation combined with zoledronic acid sequential therapy for bone metastases pain [J]. Journal of International Oncology, 2015, 42(4): 264-268.
[8]	Huang Shaojiang. Clinical observation of albumin bound paclitaxel plus bevacizumab as second line therapy in patients with advanced pancreatic cancer [J]. Journal of International Oncology, 2014, 41(8): 620-623.
[9]	He Yi, Xu Qunhong, Chen Xueqin, Pan Yuelong, Wang Ming. Effects and mechanisms of bevacizumab-induced renal impairment [J]. Journal of International Oncology, 2014, 41(8): 602-605.
[10]	SUN Shan-Shan, ZHANG Yue-Meng, GAO Ying-Jie, GAO Wen-Cang. Research progress of bonemodifying agents in the treatment of bone metastases [J]. Journal of International Oncology, 2014, 41(3): 226-228.
[11]	LIN Gang, WANG Zhun, XU Ya-Ping. Application of stereotactic body radiotherapy in extracranial metastases [J]. Journal of International Oncology, 2014, 41(11): 820-823.
[12]	Pan Xuefeng, Xing Hongyu, Zheng Guobao. Bevacizumab for glioma and radiation encephalic necrosis [J]. Journal of International Oncology, 2014, 41(1): 27-30.
[13]	SUN Shan-Shan, GAO Wen-Cang-. Research progress of bone metabolic markers [J]. Journal of International Oncology, 2013, 40(7): 546-548.
[14]	WU Yu-Li, 吕Chao , ZHENG Duo, WU Shuo-Dong. Research about Bevacizumab combined with FOLFOX protocol to treat metastasis colorectal cancer [J]. Journal of International Oncology, 2013, 40(7): 503-506.
[15]	DAI Li-Ming, LI Zhi-Qiang. Influence of bevacizumab on the invasion of glioma and the mechanism [J]. Journal of International Oncology, 2012, 39(4): 259-261.